Empagliflozin Improves Left Atrial Strain in Patients With Type 2 Diabetes: Data From a Randomized, Placebo-Controlled Study
Kirsten Thiele, Matthias Rau, Julian Grebe, Niels‐Ulrik Korbinian Hartmann, Ertunc Altiok, Michael Böhm, András Keszei, Nikolaus Marx, Michael Lehrke
Topics & Concepts
EmpagliflozinMedicinePlaceboType 2 diabetesInternal medicineCardiologyRandomized controlled trialDiabetes mellitusEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Management and Research